. Author manuscript; available in PMC: 2024 Sep 26.

Published in final edited form as: J Infect. 2022 Mar 1;84(5):658–667. doi: 10.1016/j.jinf.2022.02.032

Table 1.

Serum bactericidal titres after a single dose of PorA P1.7,16 and F3–3 expressing Adenoviral vectors. SBA titres at 16 weeks post vaccination for Ad-P1.7,16 and Ad-F3–3 expressing adenoviral vaccines measured against target strain 44/76-SL, using baby rabbit complement and pooled mouse sera (N = 4 to 8 as described in Figs. 2 and 3).

PorA P1.7,16 vaccines	rSBA titre	FetA F3–3 vaccines	rSBA titre
Empty Vector	< 1:4	Ad-F3–3	< 1:4
Ad-P1.7,16	< 1:4	Ad-FliC-F3–3	< 1:4
Ad-Cytosolic-P1.7,16	< 1:4	Naive	< 1:4
Ad-FliC-VR1.7	< 1:4
Ad-FliC-VR1.7-C	< 1:4
Ad-FliC-VR1.7-IMX313	< 1:4
Anti-1.7 mAb control	1:800
Anti-1.16 mAb control	1:6400